Floatz logo

Posaconazole

Candidiasis, Invasive

Bochud Pierre-YvesSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Candidiasis, Invasive cohort.

Asset / SponsorPhaseRating
Fluconazole
Radboud University Medical Center
Phase 4BB

Same molecule, other indications

Posaconazole is also rated in:

acute myeloid leukemiaActive
BBB
Indicative · Phase 4
74 / 100
View asset →
fungal infectious diseaseActive
BB
Indicative · Phase 4
70 / 100
View asset →
neutropeniaDormant
BB
Indicative · Phase 4
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →